Literature DB >> 11526149

Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.

J Silva1, R Gatica, C Aguilar, Z Becerra, U Garza-Ramos, M Velázquez, G Miranda, B Leaños, F Solórzano, G Echániz.   

Abstract

Thirty-one strains of Klebsiella pneumoniae (including 10 duplicates) from 21 septicemic pediatric patients (age, <2 months) were studied during a 4-month period (June to October 1996) in which the fatality rate was 62% (13 of 21). These isolates identified by the API 20E system yielded the same biotype. Pulsed-field gel electrophoresis experiments revealed the same clone in 31 strains. The isolates were multidrug-resistant but were still susceptible to ciprofloxacin, imipenem, and cefoxitin. A 135-kb plasmid was harbored in all of the isolates. No transconjugants were obtained that were resistant to ampicillin, cefotaxime, tetracycline, or gentamicin. Isoelectric focusing for beta-lactamases was performed on all strains, and three bands with pIs of 5.4, 7.6, and 8.2 were obtained. Of these, the pI 8.2 beta-lactamase had an extended-spectrum beta-lactamase phenotype. PCR amplification of both TEM- and SHV-type genes was obtained. The sequence analysis of the SHV PCR product indicated a mutation corresponding to the SHV-5 beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526149      PMCID: PMC88317          DOI: 10.1128/JCM.39.9.3193-3196.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid.

Authors:  D Billot-Klein; L Gutmann; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 2.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 3.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1).

Authors:  M Barthélémy; J Peduzzi; R Labia
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

5.  A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.

Authors:  L J Piddock; E A Traynor; R Wise
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

6.  Extended-spectrum beta-lactamases in clinical isolates of enterobacteria in Mexico.

Authors:  J Silva; C Aguilar; Z Becerra; F López-Antuñano; R García
Journal:  Microb Drug Resist       Date:  1999       Impact factor: 3.431

7.  Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli.

Authors:  T Kieser
Journal:  Plasmid       Date:  1984-07       Impact factor: 3.466

8.  Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV, CARB) [corrected].

Authors:  G Arlet; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1991-07-15       Impact factor: 2.742

9.  Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.

Authors:  M Gniadkowski; A Palucha; P Grzesiowski; W Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Authors:  C Brun-Buisson; P Legrand; A Philippon; F Montravers; M Ansquer; J Duval
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

View more
  12 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta-lactamase in a Mexican pediatric hospital.

Authors:  Guadalupe Miranda; Natividad Castro; Blanca Leaños; Adriana Valenzuela; Ulises Garza-Ramos; Teresa Rojas; Fortino Solórzano; Lilia Chihu; Jesús Silva
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 3.  Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.

Authors:  Frauke Mattner; Franz-C Bange; Elisabeth Meyer; Harald Seifert; Thomas A Wichelhaus; Iris F Chaberny
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

Review 4.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.

Authors:  Branka Bedenić; Lucija Pešorda; Marija Krilanović; Nataša Beader; Zoran Veir; Silvia Schoenthaler; Daniela Bandić-Pavlović; Sonja Frančula-Zaninović; Ivan Barišić
Journal:  Curr Microbiol       Date:  2022-10-15       Impact factor: 2.343

6.  Use of multienzyme multiplex PCR amplified fragment length polymorphism typing in analysis of outbreaks of multiresistant Klebsiella pneumoniae in an intensive care unit.

Authors:  Anneke van der Zee; Niels Steer; Eveline Thijssen; Jolande Nelson; Annemarie van't Veen; Anton Buiting
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins.

Authors:  Monica Cartelle; Maria del Mar Tomas; Sonia Pertega; Alejandro Beceiro; M Angeles Dominguez; David Velasco; Francisca Molina; Rosa Villanueva; German Bou
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology.

Authors:  K Kristóf; D Szabó; J W Marsh; V Cser; L Janik; F Rozgonyi; A Nobilis; K Nagy; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

Review 9.  Mechanisms of Resistance in Gram-Negative Urinary Pathogens: From Country-Specific Molecular Insights to Global Clinical Relevance.

Authors:  Branka Bedenić; Tomislav Meštrović
Journal:  Diagnostics (Basel)       Date:  2021-04-28

10.  Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.

Authors:  Patricia Cornejo-Juárez; Carolina Pérez-Jiménez; Jesús Silva-Sánchez; Consuelo Velázquez-Acosta; Fernanda González-Lara; Fernando Reyna-Flores; Alejandro Sánchez-Pérez; Patricia Volkow-Fernández
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.